Zoetis (ZTS) Shares Outstanding (2012 - 2026)
Zoetis (ZTS) posted quarterly Shares Outstanding (Entity) of $501.9 million for Q1 2026, little changed year-over-year from $501.9 million in Q1 2025, and little changed quarter-over-quarter from $501.9 million in Q4 2025.
Zoetis (ZTS) Shares Outstanding (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Shares Outstanding (Entity) for 15 consecutive years, with $501.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) changed 0.0% year-over-year to $501.9 million; the TTM figure through Mar 2026 stood at $501.9 million (changed 0.0% YoY), while the FY2025 annual figure was $501.9 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) was little changed at $501.9 million in Q1 2026 per ZTS's latest filing, from $501.9 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $501.9 million in Q1 2022 and bottomed at $501.9 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $501.9 million across 5 years, with a median of $501.9 million in 2022.
- On a YoY basis, Shares Outstanding (Entity) climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
- Zoetis' Shares Outstanding (Entity) stood at $501.9 million in 2022, then changed by 0.0% to $501.9 million in 2023, then changed by 0.0% to $501.9 million in 2024, then changed by 0.0% to $501.9 million in 2025, then changed by 0.0% to $501.9 million in 2026.
- Business Quant data shows ZTS's Shares Outstanding (Entity) at $501.9 million in Q1 2026, $501.9 million in Q4 2025, and $501.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 167.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 417.60 Mn |
| Mar 31, 2026 | 422.10 Mn |
| Dec 31, 2025 | 443.44 Mn |
| Sep 30, 2025 | 442.90 Mn |
| Jun 30, 2025 | 445.10 Mn |
| Mar 31, 2025 | 447.60 Mn |
| Dec 31, 2024 | 454.20 Mn |
| Sep 30, 2024 | 452.90 Mn |
| Jun 30, 2024 | 455.50 Mn |
| Mar 31, 2024 | 458.00 Mn |
| Dec 31, 2023 | 461.17 Mn |
| Sep 30, 2023 | 460.30 Mn |
| Jun 30, 2023 | 461.90 Mn |
| Mar 31, 2023 | 463.50 Mn |
| Dec 31, 2022 | 468.89 Mn |
| Sep 30, 2022 | 467.80 Mn |
| Jun 30, 2022 | 470.00 Mn |
| Mar 31, 2022 | 472.20 Mn |
| Dec 31, 2021 | 474.35 Mn |
| Sep 30, 2021 | 474.00 Mn |